Expect higher prices and slightly fewer flights, especially on some less-traveled routes, experts say
MarketWatch
Here’s how to manage up — and get promoted — if you’re not in the office every day
Four years after many office employees embraced remote work as a permanent piece of their schedule, experts say it’s still easier to be a star employee in person.
Five ways to reduce your taxable income for 2024
“By shrinking your income, you’re saving money. That’s the bottom line.”
UBS restarts share buybacks with program of up to $2 billion
UBS Group said it plans to repurchase up to $2 billion of its own stock, restarting share buybacks that were put on hold last year due to its acquisition of Credit Suisse.
Country Garden shares suspended from Hong Kong stock exchange
The heavily-indebted property developer halted trading of its shares pending publication of its 2023 results
Benchmark Treasury yield holds near four-month high after stronger U.S. economic data
U.S. bond yields were a touch higher early Tuesday, as investors continued to reduce bets on Federal Reserve interest rate cuts following stronger-than-expected data on Monday.
This boring sector is becoming sexy again
Some of the hardest companies to get excited about are construction companies — but they’re outperforming the market.
Healthcare stocks fade as obesity-drug optimism fades
Healthcare companies fell sharply Monday as ebullience about a new class of weight control drugs subsided.
Rubrik files for IPO as market continues to display signs of unfreezing
Investors hungry for more technology IPOs look to be getting another one soon, as cybersecurity company Rubrik just filed paperwork for a stock-market debut.
Acorda Therapeutics shares sink nearly 40% after bankruptcy filing
Shares of Acorda Therapeutics fell late Monday after the company said it had filed for bankruptcy protection.